Pfizer vs. Libyan Forces: The Company Defends Viagra

By The Atlantic Wire

Pfizer, we imagine, wasn't too happy about the shout-out its Viagra product got yesterday when International Criminal Court prosecutor Luis Moreno-Ocampo announced, as part of his investigation into whether the Libyan government is authorizing rape as a weapon of war, that he had evidence of Muammar Qaddafi's regime buying containers of "Viagra-type" drugs "to enhance the possibility of rape" (Ocampo has already requested an arrest warrant for Qaddafi on charges of crimes against humanity).

To be sure, a Pfizer spokesperson, borrowing language initially employed in a May 18 press release, mainly expressed concern for the people of Libya, noting that the company is "appalled" by the alleged abuse and "condemns the misuse of any of its medicines," according to Sky News. But one also assumes Pfizer is concerned that the association of systematic rape with its impotency drug could damage the Viagra brand, which accounts for $1.9 billion in sales per year.

Read the full story at The Atlantic Wire.

This article available online at:

http://www.theatlantic.com/health/archive/2011/06/pfizer-vs-libyan-forces-the-company-defends-viagra/240221/